AiViva Biopharma Appoints Jung-Chin (Rongjin) Lin, to the Board of Directors
August 29, 2023 19:00 ET
|
AiViva Biopharma
COSTA MESA, Calif., Aug. 29, 2023 (GLOBE NEWSWIRE) -- AiViva Biopharma Inc., a clinical-stage biotechnology company developing innovative therapies to address major unmet medical needs, today...
Iridex Announces Strategic Review to Unlock Shareholder Value
August 29, 2023 16:05 ET
|
IRIDEX Corporation
MOUNTAIN VIEW, Calif., Aug. 29, 2023 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX) announced today that its Board of Directors is undertaking, in consultation with its financial and legal...
Innovation Pharmaceuticals Announces New Milestone at BeaMed; On Track to File 510(k) Submission to FDA in Q2 2024
August 28, 2023 08:00 ET
|
Innovation Pharmaceuticals Inc
WAKEFIELD, MA, Aug. 28, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company and minority stakeholder in...
Abstract on ZETA-1 Study of APX3330 Receives Award at Women in Ophthalmology (WIO) Summer Symposium
August 28, 2023 08:00 ET
|
Ocuphire Pharma
FARMINGTON HILLS, Mich., Aug. 28, 2023 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing...
Atsena Therapeutics Announces First Patient Dosed in Phase I/II Clinical Trial of ATSN-201 for the Treatment of X-linked Retinoschisis
August 28, 2023 07:30 ET
|
Atsena Therapeutics
The LIGHTHOUSE study evaluating the safety and tolerability of investigational gene therapy ATSN-201 is enrolling male patients ages 6-64 with RS1-associated XLRS ATSN-201 leverages novel spreading...
China Medical System Gained Exclusive License of an Anti-Ischemic Stroke Class 1 Innovative Drug
August 24, 2023 08:00 ET
|
China Medical System Holdings Ltd.
SHENZHEN, CHINA, Aug. 24, 2023 (GLOBE NEWSWIRE) -- Y-3, a Class 1 Innovative Drug injection, is used to alleviate neurological symptoms and dysfunction of daily activities caused by acute ischemic...
Veterinary Eye Institute Opens in Gainesville, FL, Providing Advanced, Specialty Ophthalmology Care for Pets
August 22, 2023 11:28 ET
|
MedVet Associates, Ltd.
WORTHINGTON, Ohio, Aug. 22, 2023 (GLOBE NEWSWIRE) -- Veterinary Eye Institute (VEI) in Gainesville, FL, is now open to pets, their loving families, and the veterinary community in Gainesville and...
Ashvattha Therapeutics Presents Promising Preclinical Data on New Dendranib Nanomedicine Candidate ASH41020 at the 16th International Society of Neuroimmunology Congress (ISNI)
August 22, 2023 08:30 ET
|
Ashvattha Therapeutics
Data demonstrated that ASH41020, a novel CSFR1 tyrosine kinase inhibitor ‘dendranib’, directs macrophage polarization toward the anti-inflammatory M2 phenotypeASH41020 treatment lessened disease...
Laser Therapy Devices Market to Surpass 2.84 Billion by 2030 Drives Due to Increasing Adoption of Laser Technology
August 21, 2023 06:30 ET
|
SkyQuest Technology Consulting Pvt. Ltd.
Westford, USA, Aug. 21, 2023 (GLOBE NEWSWIRE) -- According to SkyQuest, laser therapy devices have become indispensable tools in the field of medical treatment and are widely utilized across various...
Another Medicine to Stop Migraine in its Tracks – Zavzpret™ is Now Available, but Where will Neurologists use it?
August 17, 2023 14:57 ET
|
Spherix Global Insights
Exton, Pennsylvania, Aug. 17, 2023 (GLOBE NEWSWIRE) -- In February 2023, Pfizer published their positive Phase 3 clinical trial results for zavegepant (new brand name, Zavzpret™). At the time,...